Richard M Weinshilboum, MD

  • 27607 Citations
  • 84 Scopus h-Index
1968 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1968 2020

Filter
Review article
2019
Open Access
Artificial Intelligence
Pharmacogenetics
Antidepressive Agents
Biomarkers
Machine Learning
1 Citation (Scopus)

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases

Zhu, Y., Swanson, K. M., Rojas, R. L., Wang, Z., St. Sauver, J. L., Visscher, S. L., Prokop, L. J., Bielinski, S. J., Wang, L., Weinshilboum, R. & Borah, B. J., Jan 1 2019, (Accepted/In press) In : Genetics in Medicine.

Research output: Contribution to journalReview article

Open Access
Pharmacogenetics
Cost-Benefit Analysis
Cardiovascular Diseases
Costs and Cost Analysis
Cost of Illness
2018
8 Citations (Scopus)

The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases

Neavin, D. R., Liu, D., Ray, B. & Weinshilboum, R. M., Dec 1 2018, In : International Journal of Molecular Sciences. 19, 12, 3851.

Research output: Contribution to journalReview article

Aryl Hydrocarbon Receptors
Immune System Diseases
hydrocarbons
Hydrocarbons
Nucleotides
2017
23 Citations (Scopus)
Clinical Decision Support Systems
Electronic Health Records
Pharmacogenetics
Precision Medicine
Cognition
27 Citations (Scopus)

Pharmacogenomics: Precision Medicine and Drug Response

Weinshilboum, R. M. & Wang, L. M., Nov 1 2017, In : Mayo Clinic Proceedings. 92, 11, p. 1711-1722 12 p.

Research output: Contribution to journalReview article

Precision Medicine
Pharmacogenetics
Pharmaceutical Preparations
Electronic Health Records
Human Genome